Erratum: Transient telomere dysfunction induces chromosomal instability and promotes carcinogenesis (Journal of Clinical Investigation (2012) 122:6 (2283-2288) DOI: 10.1172/JCI61745);Transient telomere dysfunction induces chromosomal instability and promotes carcinogenesis

Journal of Clinical Investigation

Volumn 122, Issue 6, 2012, Pages 2283-2288

  Begus Nahrmann, Yvonne ^a   Hartmann, Daniel ^b,c   Kraus, Johann ^b   Eshraghi, Parisa ^b   Scheffold, Annika ^b   Grieb, Melanie ^b   Rasche, Volker ^b   Schirmacher, Peter ^d   Lee, Han Wong ^e   Kestler, Hans A ^b   Lechel, André ^b   Rudolph, K Lenhard ^b  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^e Yonsei University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CHROMOSOMAL INSTABILITY; CHROMOSOME ABERRATION; CONTROLLED STUDY; DISEASE MODEL; DNA DAMAGE; FEMALE; HUMAN; IN VIVO STUDY; KNOCKOUT MOUSE; LIVER CARCINOGENESIS; LIVER TUMOR; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TELOMERE SHORTENING; TUMOR GROWTH;

EID: 84861794399     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI145852     Document Type: Erratum

References (25)

1. Maser RS, DePinho RA. Connecting chromosomes, crisis, and cancer. Science. 2002;297(5581):565-569. (Pubitemid 34815334)
2. Kim NW, et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 1994;266(5193):2011-2015.
3. Farazi PA, Glickman J, Jiang S, Yu A, Rudolph KL, DePinho RA. Differential impact of telomere dysfunction on initiation and progression of hepatocellular carcinoma. Cancer Res. 2003;63(16):5021-5027. (Pubitemid 37022640)
4. Greenberg RA, Allsopp RC, Chin L, Morin GB, DePinho RA. Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation. Oncogene. 1998;16(13):1723-1730. (Pubitemid 28175053)
5. Hu J, et al. Antitelomerase therapy provokes ALT and mitochondrial adaptive mechanisms in cancer. Cell. 2012;148(4):651-663.
6. Lechel A, et al. Telomerase deletion limits progression of p53-mutant hepatocellular carcinoma with short telomeres in chronic liver disease. Gastroenterology. 2007;132(4):1465-1475. (Pubitemid 46627579)
7. Rudolph KL, Millard M, Bosenberg MW, DePinho RA. Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nat Genet. 2001;28(2):155-159. (Pubitemid 32538061)
8. Rudolph KL, et al. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell. 1999;96(5):701-712. (Pubitemid 29122812)
9. Artandi SE, et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature. 2000;406(6796):641-645.
10. Satyanarayana A, Manns MP, Rudolph KL. Telomeres and telomerase: a dual role in hepatocarcinogenesis. Hepatology. 2004;40(2):276-283. (Pubitemid 39062843)
11. Miura N, et al. Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis. Cancer Genet Cytogenet. 1997;93(1):56-62. (Pubitemid 27102490)
12. Plentz RR, et al. Telomere shortening correlates with increasing aneuploidy of chromosome 8 in human hepatocellular carcinoma. Hepatology. 2005;42(3):522-526. (Pubitemid 41233641)
13. van Steensel B, Smogorzewska A, de Lange T. TRF2 protects human telomeres from end-to-end fusions. Cell. 1998;92(3):401-413. (Pubitemid 28093017)
14. Karlseder J, Broccoli D, Dai Y, Hardy S, de Lange T. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science. 1999;283(5406):1321-1325.
15. Naugler WE, et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science. 2007;317(5834):121-124. (Pubitemid 47056470)
16. Greenberg RA, et al. Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta2/3) cancer-prone mouse. Cell. 1999;97(4):515-525. (Pubitemid 29231174)
17. Blasco MA, et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell. 1997;91(1):25-34. (Pubitemid 27431310)
18. Baudis M, Cleary ML. Progenetix.net: an online repository for molecular cytogenetic aberration data. Bioinformatics. 2001;17(12):1228-1229. (Pubitemid 33735351)
19. Ruggero D, Pandolfi PP. Does the ribosome translate cancer? Nat Rev Cancer. 2003;3(3):179-192. (Pubitemid 37328870)
20. Lechel A, et al. The cellular level of telomere dysfunction determines induction of senescence or apoptosis in vivo. EMBO Rep. 2005;6(3):275-281. (Pubitemid 40485625)
21. Smogorzewska A, de Lange T. Different telomere damage signaling pathways in human and mouse cells. EMBO J. 2002;21(16):4338-4348.
22. Poncet D, et al. Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B-chronic lymphocytic leukemia. Blood. 2008;111(4):2388-2391. (Pubitemid 351451451)
23. Raynaud CM, et al. Telomere shortening is correlated with the DNA damage response and telomeric protein down-regulation in colorectal preneoplastic lesions. Ann Oncol. 2008;19(11):1875-1881.
24. Ding Z, et al. Telomerase reactivation following telomere dysfunction yields murine prostate tumors with bone metastases. Cell. 2012;148(5):896-907.
25. Schonig K, Schwenk F, Rajewsky K, Bujard H. Stringent doxycycline dependent control of CRE recombinase in vivo. Nucleic Acids Res. 2002;30(23):e134.